[1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001777:Blood Coagulation; D001798:Blood Proteins / Q000627:therapeutic use; D001799:Blood Sedimentation; D003490:Cyanosis / Q000139:chemically induced*; D004381:Duodenal Ulcer / Q000601:surgery; D004417:Dyspnea / Q000139:chemically induced*; D005396:Fish Products; D005399:Fishes; D005770:Gastrointestinal Neoplasms / Q000601:surgery; D005780:Gelatin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006400:Hematocrit; D059685:Herniorrhaphy; D006801:Humans; D008875:Middle Aged; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care; D012768:Shivering; D012867:Skin
D001798:Blood Proteins; D010952:Plasma Substitutes; D005780:Gelatin
Erste klinische Prüfung eines neuen hochmolekularen Plasmaersatzstoffes auf Gelatinegrundlage.